As expected, gemcitabine inhibited tumor growth in vivo, and NDRG2 knockdown partly recovered the malignant tumor growth and proliferation in nude mice that was suppressed by gemcitabine (Figure 7A, 7B and S5). Here, NDRG2 is linked to neoplasm.